Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of FDA Orange Book Patents covering Metaxalone

Client Email

Product

Metaxalone
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

Bora Pharmaceuticals- Making success more certain.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

Contact Supplier

Axplora- The partner of choice for complex APIs.

Contact Supplier

Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

Contact Supplier

Metaxalone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

26 API Suppliers, 19 USDMF, 1 EU WC, 8 NDC API, 12 Listed Suppliers, $ API Reference Price

26 API Suppliers
19 USDMF
1 EU WC
8 NDC API
12 Listed Suppliers
$ API Reference Price

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Imports

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

13 FDF Dossiers, 12 FDA Orange Book, 1 Listed Dossiers

13 FDF Dossiers
12 FDA Orange Book
1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 Rochem International Inc, 8 SPI Pharma, 3 DKSH, 1 Jai Radhe Sales, 6 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 13 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 1 Aeon Procare, 3 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 19 BASF, 11 Corel Pharma Chem, 5 DFE Pharma, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 6 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 29 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 NEWEDGE Overseas, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 41 Direct Compression, 28 Controlled & Modified Release, 27 Lubricants & Glidants, 25 Disintegrants & Superdisintegrants, 24 Granulation, 22 Thickeners and Stabilizers, 16 Film Formers & Plasticizers, 16 Co-Processed Excipients, 14 Solubilizers, 11 Taste Masking, 10 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 6 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Parenteral, 2 Coloring Agents, 2 Topical, 1 Surfactant & Foaming Agents

78 Fillers, Diluents & Binders
51 Coating Systems & Additives
41 Direct Compression
28 Controlled & Modified Release
27 Lubricants & Glidants
25 Disintegrants & Superdisintegrants
24 Granulation
22 Thickeners and Stabilizers
16 Film Formers & Plasticizers
16 Co-Processed Excipients
14 Solubilizers
11 Taste Masking
10 Chewable & Orodispersible Aids
7 Emulsifying Agents
6 API Stability Enhancers
5 Rheology Modifiers
5 Empty Capsules
4 Vegetarian Capsules
3 Parenteral
2 Coloring Agents
2 Topical
1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 6 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
6 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

2 US Medicaid Prescriptions

MARKET PLACE

4 APIs

4 APIs

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

3 USP, 4 Others

3 USP
4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 149 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 1KING PHARMS

02 1PRIMUS PHARMS

filter Patent Number Reset all filters

2 All

01 17122566

02 111918559

filter API Patent Reset all filters

2 All

01 2Blank

filter FDF Patent Reset all filters

2 All

01 1Y

02 1Blank

filter Expiration Date Reset all filters

2 All

01 12026-02-06

02 12039-07-29

Product Main Page

01

KING PHARMS

Luxepack

Not Confirmed

KING PHARMS

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-02-06

US Patent Number : 7122566

Drug Substance Claim :

Drug Product Claim :

Application Number : 13217

Patent Use Code : U-915

Delist Requested :

Patent Use Description : TREATMENT OF MUSCULOSK...

Patent Expiration Date : 2026-02-06

Portfolio PDF

Product Web Link

Digital Content

02

PRIMUS PHARMS

Luxepack

Not Confirmed

PRIMUS PHARMS

Luxepack

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2039-07-29

US Patent Number : 11918559

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22503

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-07-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?